GLARGINE

作品数：42被引量：44H指数：3
导出分析报告
相关领域：医药卫生更多>>
相关作者：傅静奕丁丽丽郭辉李素霞张晓凡更多>>
相关机构：新乡市第一人民医院河南科技大学三明市第一医院昆山市第一人民医院更多>>
相关期刊：《国外药讯》《基层医学论坛》《国际内分泌代谢杂志》《Journal of Diabetes Mellitus》更多>>
相关基金：国家自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 主题=INSULINx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Glargine-300: An updated literature review on randomized controlled trials and real-world studies
《World Journal of Diabetes》2020年第4期100-114,共15页Sujoy Ghosh Romik Ghosh 
Despite the availability of a variety of insulins,rates of insulinisation and the acceptance of insulin therapy is suboptimal in real-world clinical settings.Patient and physician concerns with hypoglycaemia and weigh...
关键词：INSULIN Glargine-300 Type 2 DIABETES DIABETES MELLITUS HYPOGLYCAEMIA Glycaemic control 
Assessment of Safety and Effectiveness of Glaritus<sup>®</sup>(Wockhardt’s Insulin Glargine) in a Prospective, Multi-Centric Post Marketing Observational Study in Nepalese Having Type 2 Diabetes Mellitus
《Open Journal of Endocrine and Metabolic Diseases》2019年第2期21-33,共13页Ansumali Joshi Bhojraj Adhikari Basant Tamrakar Gaurav Puppalwar Agam Shah Rishi Jain 
Background: Nepal is one of the fastest urbanizing countries in South Asia and is facing the consequences of urban lifestyle leading to obesity and metabolic syndrome. Type 2 diabetes mellitus (T2DM) is currently a hi...
关键词：INSULIN GLARGINE Type 2 Diabetes NEPALESE Patients Hypoglycemia Basal INSULIN HbA1c Fasting Plasma Glucose POST MARKETING Surveillance 
Effect of Insulin Glargine on Cardiovascular Risk Analysed by Mean HRV
《Health》2019年第1期20-24,共5页Marchitto Nicola Marcinnò Mariaconcetta Petrucci Alessia Apicella Giovanni Dal Maso Serenella Gioia Raimondi Gianfranco 
Type 2 diabetes mellitus is an insidious disease that is increasingly present in geriatric population [1]. The greatest difficulty is represented by glycaemic control in geriatric patients often not very compliant wit...
关键词：INSULIN GLARGINE DIABETES HRV CARDIOVASCULAR RISK Geriatry 
Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus®with Reference Product— Lantus®: Study Protocol &Early Data Trends
《Open Journal of Endocrine and Metabolic Diseases》2018年第8期157-166,共10页S. K. Sharma A. K. Ajmani P. Khosla P. Mukhopadhyay G. Bhatia K. G. Prakash G. Chhaya P. D. Supe V. Pavithran H. Bora R. Jain S. Ingole A. Shah 
Objective: Present Phase IV Trial is aimed at evaluating the immunogenicity, safety, and efficacy of Wockhardt’s insulin glargine, Glaritus®in comparison with reference insulin glargine, Lantus®in subjects wi...
关键词：INSULIN ANTIBODIES IMMUNOGENICITY INSULIN GLARGINE BIOSIMILAR HBA1C 
Effect of Initiation of Basal Insulin Glargine on Glycemic Control in Patients with Diabetes: Real Life Experience from Hong Kong
《Journal of Diabetes Mellitus》2017年第3期108-120,共13页Chi-Kin Yeung Fhkcp Fhkam Wilson Wai-man Ngai Ip-tim Lau 
Introduction: To assess the changes in glycemic control after initiating or switching to a basal insulin analogue in patients with diabetes mellitus. Methods: A retrospective, observational analysis was conducted usin...
关键词：Glycemic Control INSULIN INITIATION INSULIN GLARGINE TYPE 1 DIABETES MELLITUS TYPE 2 DIABETES MELLITUS Hong Kong 
Evaluation of Safety and Efficacy of Glaritus<sup>®</sup>versus Lantus<sup>®</sup>in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study
《Open Journal of Endocrine and Metabolic Diseases》2017年第4期111-125,共15页Gaurav Puppalwar Sandesh Sawant Bhimsen Silgiri Kirti Shukla Hanmant Barkate 
Objective: The present study assessed safety and efficacy of Glaritus®among adults with Type 1 Diabetes Mellitus (T1DM). Methodology: This prospective, randomized, multicenter, comparative, non-inferiority, open-l...
关键词：Diabetes Mellitus INSULIN GLARGINE INSULIN LISPRO 
Simple Insulin Dose Adjustment Using 3-3-1 Algorithm in Japanese Patients with Type 2 Diabetes: Start Kanazawa Study (Self-Titration Aggressive Algorithm with Glargine Trial)被引量：1
《Journal of Diabetes Mellitus》2016年第3期197-203,共7页Kenji D. Furukawa Naoto Yamaaki Aya Fujimoto Kiminori Ohyama Hiroaki Muramoto 
We implemented a 3-3-1 algorithm in order to provide safe and simple self-titration in patients who newly initiated BOT as well as who were already on BOT and evaluated its utility in clinical setting. A total of 46 p...
关键词：GLARGINE Self-Titration BOT T2DM INSULIN 3-3-1 Algorithm 
Treatment Satisfaction with Insulin Glargine in Insulin-Naïve Type 2 Diabetes Patients—A Hong Kong Based Registry
《Journal of Diabetes Mellitus》2014年第3期232-241,共10页Wing-Bun Chan Wilson W. M. Ngai Peter Chun-Yip Tong 
Objective: To evaluate patient satisfaction with insulin glargine. Design: Multicentre observational registry. Data were collected at baseline/inclusion visit, and 12 and 24 weeks. Setting: Physicians in Hong Kong, wh...
关键词：INSULIN GLARGINE Patient SATISFACTION Hong Kong Type 2 Diabetes MELLITUS 
Efficacy and Safety of Patient-Led Dosage Adjustments of Insulin Glargine: A Preliminary Report of Basal-Supported Oral Therapy for Japanese Type 2 Diabetes Patients
《Journal of Diabetes Mellitus》2014年第2期77-84,共8页Shuhei Nakanishi Mitsunobu Kubota Rui Kishimoto 
To evaluate the clinical utility for simple patient administered dose adjustment methods of insulin glargine during outpatient visits compared with a physician managed titration, changes in HbA1c and total daily dose ...
关键词：GLARGINE Self-Titration BOT T2DM INSULIN 
Assessing insulin effectiveness at the end of the day: Once-daily versus twice-daily insulin glargine injection
《Journal of Diabetes Mellitus》2012年第2期203-207,共5页Mark R. Burge Eric R. Schroeder Stephen Mitchell 
Objective: Evidence supporting the twice-daily administration of insulin glargine as an approach to address its waning effectiveness at the end of a 24 hour period is sparse. We hypothesized that insulin concentration...
关键词：INSULIN INJECTION Timing INSULIN GLARGINE BASAL INSULIN Type 1 Diabetes 
全选清除导出
共2页<12>
检索报告 对象比较 聚类工具 使用帮助 返回顶部